Emergence and clonal expansion of Aeromonas hydrophila ST1172 that simultaneously produces MOX-13 and OXA-724

Table 2 Antimicrobial susceptibility patterns of three A. hydrophila isolates

Antibiotic class	Antibiotic	19B23009 (Patient 1)		19W05620 (Patient 3)		19W06265 (Patient 4)
		MIC / Inhibition diameter (µg/mL/mm)	Interpretation	MIC / Inhibition diameter (µg/mL/mm)	Interpretation	MIC / Inhibition diameter (µg/mL/mm)	Interpretation
β-Lactams	Piperacillin/Tazobactam	≥ 128	Resistant	≥ 128	Resistant	≥ 128	Resistant
	Ceftriaxone	8	Resistant	≥ 64	Resistant	8	Resistant
	Ceftazidime	2	Susceptible	≥ 64	Resistant	2	Susceptible
	Cefepime	≤ 0.12	Susceptible	4	Intermediate	≤ 0.12	Susceptible
	Cefoperazone/Sulbactam	16	No criteria	≥ 64	No criteria	16	No criteria
	Cefuroxime	≥ 64	Resistant	≥ 64	Resistant	≥ 64	Resistant
	Cefoxitin	≥ 64	Resistant	≥ 64	Resistant	≥ 64	Resistant
	Imipenem	8	Resistant	8	Resistant	8	Resistant
	Meropenem	31	Susceptible	13	Resistant	26	Susceptible
	Amoxycillin/clavulanic acid	4	No criteria	≥ 32	No criteria	4	No criteria
Aminoglycoside	Amikacin	≤ 2	Susceptible	≤ 2	Susceptible	≤ 2	Susceptible
Trimethoprim-sulfonamide	Trimethoprim-Sulfonamide	8	No criteria	≥ 16	No criteria	8	No criteria
Fluoroquinolone	Levofloxacin	0.5	Susceptible	2	Susceptible	0.5	Susceptible
Glycylcycline	Tigecycline	≤ 0.05	No criteria	≤ 0.05	No criteria	≤ 0.05	No criteria

ISSN: 2047-2994